Olema Pharmaceuticals OLMA
NASDAQ OLMA
$10.75 +0.02 (+0.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026)

Olema Pharmaceuticals (OLMA) posted quarterly Prepaid Assets of $1.2 million for Q1 2026, up 345.65% year-over-year from $276000.0 in Q1 2025, and down 87.72% quarter-over-quarter from $10.0 million in Q4 2025.

Analysis

Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026) Analysis & Trends

Olema Pharmaceuticals (OLMA) has reported Prepaid Assets for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 345.65% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 345.65% YoY), while the FY2025 annual figure was $10.0 million, up 869.51% from the prior year.
  • Prepaid Assets fell to $1.2 million in Q1 2026 per OLMA's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $10.0 million in Q4 2025 and bottomed at $129000.0 in Q4 2022.
  • Historically, Prepaid Assets has averaged $2.0 million across 5 years, with a median of $1.2 million in 2026.
  • Annual changes were most pronounced in 2023 — Prepaid Assets slumped 89.76% — and 2024, when it jumped 1200.84%.
  • Olema Pharmaceuticals' Prepaid Assets stood at $129000.0 in 2022, then jumped by 860.47% to $1.2 million in 2023, then dropped by 16.63% to $1.0 million in 2024, then jumped by 869.51% to $10.0 million in 2025, then plunged by 87.72% to $1.2 million in 2026.
  • Business Quant data shows OLMA's Prepaid Assets at $1.2 million in Q1 2026, $10.0 million in Q4 2025, and $577000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Olema Pharmaceuticals 1.13 Bn 1.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.81 Mn
Mar 31, 2026 7.88 Mn
Dec 31, 2025 10.02 Mn
Sep 30, 2025 5.37 Mn
Jun 30, 2025 5.81 Mn
Mar 31, 2025 3.96 Mn
Dec 31, 2024 4.39 Mn
Sep 30, 2024 3.23 Mn
Jun 30, 2024 3.08 Mn
Mar 31, 2024 3.11 Mn
Dec 31, 2023 4.71 Mn
Sep 30, 2023 5.11 Mn
Jun 30, 2023 4.07 Mn
Mar 31, 2023 3.44 Mn
Dec 31, 2022 4.48 Mn
Sep 30, 2022 2.46 Mn
Jun 30, 2022 2.32 Mn
Mar 31, 2022 2.35 Mn
Dec 31, 2021 3.44 Mn
Sep 30, 2021 2.33 Mn